Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates
- 31 December 2005
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 34 (4) , 268-271
- https://doi.org/10.1016/j.jcv.2005.01.011
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Updated European Recommendations for the Clinical Use of HIV Drug Resistance TestingAntiviral Therapy, 2004
- Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA PanelClinical Infectious Diseases, 2003
- A highly prevalent polymorphism at codon 72 of HIV-1 reverse transcriptase in Argentina prevents hybridization reaction at codon 74 in the LiPA genotyping testJournal of Virological Methods, 2001
- Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European settingAIDS, 2001
- Comparison of DNA Sequencing and a Line Probe Assay for Detection of Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Patients Failing Highly Active Antiretroviral TherapyJournal of Clinical Microbiology, 2001
- Comparative Evaluation of Three Human Immunodeficiency Virus Genotyping Systems: the HIV-GenotypR Method, the HIV PRT GeneChip Assay, and the HIV-1 RT Line Probe AssayJournal of Clinical Microbiology, 2000
- Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysisJournal of Virological Methods, 1999
- Comparison of line probe assay (LIPA) and sequence analysis for detection of HIV-1 drug resistanceJournal of Medical Virology, 1999
- Evaluation of Mixtures of Wild-Type HIV-1 and HIV-1 with Resistance Point Mutations against Reverse Transcriptase InhibitorsAntiviral Therapy, 1998